Compounds > silybin
Page last updated: 2024-08-23

silybin and Triple Negative Breast Neoplasms

silybin has been researched along with Triple Negative Breast Neoplasms in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (50.00)24.3611
2020's4 (50.00)2.80

Authors

AuthorsStudies
Date, T; Dharshini, M; Gabhale, A; Ghadi, R; Jain, S; Kuche, K; Pandey, PK; Wadikar, A1
Fu, J; Fujisaki, H; Hattori, S; Hayashi, T; Ikejima, T; Liu, W; Mizuno, K; Nie, Y; Onodera, S; Si, L1
Bamezai, RN; Chattopadhyay, S; Iqbal, MA; Khan, A; Prakasam, G; Siddiqui, FA; Siddiqui, S; Sultana, S; Ur Rehman, A1
Adamii, V; Akbari, S; Chodari, L; Dariushnejad, H; Ghorbanzadeh, V; Kamali, F; Lashgarian, HE1
Byun, HJ; Darvin, P; Joung, YH; Kang, DY; Kim, SJ; Park, JH; Sp, N; Yang, YM1
Kalafatis, M; Manouchehri, JM1
Han, J; Jeon, M; Jung, T; Kil, WH; Kim, S; Lee, J; Lee, JE; Nam, SJ; Oh, SJ1
Bae, S; Han, J; Jeon, M; Kim, HJ; Kim, S; Lee, J; Lee, JE; Nam, SJ; You, D1

Other Studies

8 other study(ies) available for silybin and Triple Negative Breast Neoplasms

ArticleYear
Genipin-crosslinked albumin nanoparticles containing neratinib and silibinin: A dual-death therapy for triple negative breast cancer.
    International journal of pharmaceutics, 2023, Dec-15, Volume: 648

    Topics: Albumins; Apoptosis; Cell Line, Tumor; Humans; Nanoparticles; Silybin; Triple Negative Breast Neoplasms

2023
Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion.
    Molecular and cellular biochemistry, 2020, Volume: 463, Issue:1-2

    Topics: Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Mitochondrial Dynamics; Mitochondrial Membrane Transport Proteins; Neoplasm Proteins; Silybin; Triple Negative Breast Neoplasms

2020
Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications.
    The FEBS journal, 2021, Volume: 288, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Databases, Genetic; Datasets as Topic; Deoxyglucose; Drug Synergism; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Metabolome; Paclitaxel; Proto-Oncogene Proteins c-myc; Signal Transduction; Silybin; Survival Analysis; Triple Negative Breast Neoplasms

2021
Silibinin Inhibit Cell Migration through Downregulation of RAC1 Gene Expression in Highly Metastatic Breast Cancer Cell Line.
    Drug research, 2020, Volume: 70, Issue:10

    Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Humans; rac1 GTP-Binding Protein; Silybin; Triple Negative Breast Neoplasms

2020
Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells.
    Oncology reports, 2017, Volume: 37, Issue:6

    Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Janus Kinase 2; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Phosphorylation; Signal Transduction; Silybin; Silymarin; STAT3 Transcription Factor; Triple Negative Breast Neoplasms

2017
Sensitization of rhTRAIL-resistant Triple-negative Breast Carcinoma Through Silibinin Co-Treatment.
    Anticancer research, 2017, Volume: 37, Issue:12

    Topics: Apoptosis; Blotting, Western; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Receptors, TNF-Related Apoptosis-Inducing Ligand; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Silybin; Silymarin; Survivin; TNF-Related Apoptosis-Inducing Ligand; Triple Negative Breast Neoplasms

2017
Induction of fibronectin in response to epidermal growth factor is suppressed by silibinin through the inhibition of STAT3 in triple negative breast cancer cells.
    Oncology reports, 2014, Volume: 32, Issue:5

    Topics: Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Female; Fibronectins; Gefitinib; Humans; MCF-7 Cells; Phosphorylation; Quinazolines; Signal Transduction; Silybin; Silymarin; Triple Negative Breast Neoplasms; Tyrphostins

2014
Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:8

    Topics: Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Line, Tumor; Cell Movement; Female; Humans; Mice, Inbred BALB C; Mice, Nude; Microscopy, Confocal; Real-Time Polymerase Chain Reaction; Silybin; Silymarin; Transforming Growth Factor beta2; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2016